missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human B7-H7 Fc Biotinylated Protein
Click to view available options
Menge:
50 μg
Packungsgröße:
50 Mikrogramm
Beschreibung
Measured by its binding ability in a functional ELISA. When Recombinant Human TMIGD2/CD28H Fc Chimera (Catalog # 8316-TR ) is immobilized at 0.125 μg/mL, 100 μL/well, the concentration of Biotinylated Recombinant Human B7-H7/HHLA2 Fc Chimera that produces 50% of the optimal binding response is 0.025-0.125 μg/mL.
Spezifikation
Spezifikation
| Zugriffsnummer | Q9UM44 |
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Zusammensetzung | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Gen-ID (Entrez) | 11148 |
| Molekulargewicht | M.W. (theoretical): 64 kDa (unlabeled) |
| Name | B7H7, HERV-H LTR-associating 2, HERV-H LTR-associating protein 2, HHLA2, Human endogenous retrovirus-H long terminal repeat-associating protein 2 |
| Menge | 50 μg |
| Quelle | Human embryonic kidney cell, HEK293-derived human B7-H7/HHLA2 protein Human B7-H7/HHLA2 (Ile23-Asn344) (N-terminus) Accession # Q9UM44 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
| Lagerungsbedingungen | 12 months from date of receipt, <= -20 °C as supplied. 2 weeks, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution. |
| Endotoxin-Konzentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur